Open AccessGastrointestinal Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
Author(s) -
Lamia Aalaoui,
Mohamed Réda Khmamouche,
Mohamed Anouar Mokhlis,
Rachid Tanz,
Hassan Errihani,
Mohamed Ichou
Publication year - 2022
Publication title -
sas journal of medicine
Language(s) - English
Resource type - Journals
ISSN - 2454-5112
DOI - 10.36347/sasjm.2022.v08i02.005
Subject(s) - adverse effect , medicine , immune system , intensive care medicine , gastrointestinal tract , gastrointestinal cancer , oncology , cancer , immunology , colorectal cancer
The introduction of immune checkpoint inhibitors (ICIs) has significantly improved cancer management and survival outcomes .One third of patients exposed to ICI will develop gastrointestinal adverse events (GIAEs). Knowledge of these toxicities, along with effective management algorithms, is essential to enable early diagnosis and treatment, decreasing morbidity and mortality.